Very Mild Stroke Patients Benefit from Intravenous Tissue Plasminogen Activator Without Increase of Intracranial Hemorrhage

Intracranial Hemorrhage ◽

Stroke Patients ◽

Tissue Plasminogen ◽

Mild Stroke

Elevated urea level is associated with poor clinical outcome and increased mortality post intravenous tissue plasminogen activator in stroke patients

Journal of the Neurological Sciences ◽

10.1016/j.jns.2013.06.030 ◽

2013 ◽

Vol 332 (1-2) ◽

pp. 110-115 ◽

Cited By ~ 10

Author(s):

Yan Zhang ◽

Leonid Churilov ◽

Atte Meretoja ◽

Sarah Teo ◽

Stephen M Davis ◽

...

Keyword(s):

Clinical Outcome ◽

Plasminogen Activator ◽

Stroke Patients ◽

Poor Clinical Outcome ◽

Urea Level ◽

Microbubble Administration Accelerates Clot Lysis During Continuous 2-MHz Ultrasound Monitoring in Stroke Patients Treated With Intravenous Tissue Plasminogen Activator

Stroke ◽

10.1161/01.str.0000199064.94588.39 ◽

2006 ◽

Vol 37 (2) ◽

pp. 425-429 ◽

Cited By ~ 318

Author(s):

Carlos A. Molina ◽

Marc Ribo ◽

Marta Rubiera ◽

Joan Montaner ◽

Esteban Santamarina ◽

...

Keyword(s):

Plasminogen Activator ◽

Clot Lysis ◽

Stroke Patients ◽

Ultrasound Monitoring ◽

Intravenous tissue plasminogen activator before endovascular treatment increases symptomatic intracranial hemorrhage in patients with occlusion of the middle cerebral artery second division: subanalysis of the RESCUE-Japan Registry

Neuroradiology ◽

10.1007/s00234-015-1608-3 ◽

2015 ◽

Vol 58 (2) ◽

pp. 147-153 ◽

Cited By ~ 4

Author(s):

Toshinori Takagi ◽

◽

Shinichi Yoshimura ◽

Kazutaka Uchida ◽

Yukiko Enomoto ◽

...

Keyword(s):

Endovascular Treatment ◽

Middle Cerebral Artery ◽

Plasminogen Activator ◽

Intracranial Hemorrhage ◽

Cerebral Artery ◽

Symptomatic Intracranial Hemorrhage

Tissue Plasminogen ◽

Risk Factors for Intracranial Hemorrhage in Acute Ischemic Stroke Patients Treated With Recombinant Tissue Plasminogen Activator

Stroke ◽

10.1161/strokeaha.112.665331 ◽

2012 ◽

Vol 43 (11) ◽

pp. 2904-2909 ◽

Cited By ~ 150

Author(s):

William N. Whiteley ◽

Karsten Bruins Slot ◽

Peter Fernandes ◽

Peter Sandercock ◽

Joanna Wardlaw

Keyword(s):

Risk Factors ◽

Ischemic Stroke ◽

Acute Ischemic Stroke ◽

Plasminogen Activator ◽

Intracranial Hemorrhage ◽

Recombinant Tissue Plasminogen Activator ◽

Stroke Patients ◽

Risk of Intracranial Hemorrhage among Patients with Acute Ischemic Stroke Receiving Warfarin and Treated with Intravenous Tissue Plasminogen Activator

Journal of Emergency Medicine ◽

10.1016/j.jemermed.2012.09.002 ◽

2012 ◽

Vol 43 (5) ◽

pp. e379

Author(s):

Howard Kim

Keyword(s):

Ischemic Stroke ◽

Acute Ischemic Stroke ◽

Plasminogen Activator ◽

Intracranial Hemorrhage ◽

Drill down analysis of door-to-needle time of acute ischemic stroke patients treated with intravenous tissue plasminogen activator

The American Journal of Emergency Medicine ◽

10.1016/j.ajem.2014.08.002 ◽

2014 ◽

Vol 32 (11) ◽

pp. 1330-1333 ◽

Cited By ~ 11

Author(s):

Jon W. Schrock ◽

Marija Lum

Keyword(s):

Ischemic Stroke ◽

Acute Ischemic Stroke ◽

Plasminogen Activator ◽

Stroke Patients ◽

Tissue Plasminogen ◽

Drill Down

Intravenous Tissue Plasminogen Activator Therapy for Ischemic Stroke Patients who Caused Car Accidents

Journal of Neurology & Neurophysiology ◽

10.4172/2155-9562.1000145 ◽

2013 ◽

Vol 04 (02) ◽

Author(s):

Ichiro Deguchi

Keyword(s):

Ischemic Stroke ◽

Plasminogen Activator ◽

Stroke Patients ◽

Car Accidents ◽

Faculty Opinions recommendation of Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717647972.793102961 ◽

2012 ◽

Author(s):

Alison Baird ◽

Mateusz Adamski

Keyword(s):

Ischemic Stroke ◽

Acute Ischemic Stroke ◽

Plasminogen Activator ◽

Intracranial Hemorrhage ◽

Faculty Opinions recommendation of Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717647972.793459183 ◽

2012 ◽

Author(s):

Seemant Chaturvedi

Keyword(s):

Ischemic Stroke ◽

Acute Ischemic Stroke ◽

Plasminogen Activator ◽

Intracranial Hemorrhage ◽

Faculty Opinions recommendation of Uric acid therapy improves the outcomes of stroke patients treated with intravenous tissue plasminogen activator and mechanical thrombectomy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727677077.793574861 ◽

2020 ◽

Author(s):

David Liebeskind

Keyword(s):

Uric Acid ◽

Plasminogen Activator ◽

Mechanical Thrombectomy ◽

Stroke Patients ◽

Acid Therapy ◽